Dinoprost and ramatroban share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.176 means 18% of the combined target set is bound by both compounds. The IDF-weighted score of 0.186 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Dinoprost and ramatroban have in common?
Dinoprost and ramatroban share 3 molecular targets with a Jaccard similarity of 18%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Dinoprost and ramatroban be combined?
Dinoprost and ramatroban share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Dinoprost or ramatroban?
In the BiohacksAI corpus: Dinoprost has 252 PubMed-indexed studies, ramatroban has 0 studies.